New Brazilian law favors home treatment of cancer patients

20 November 2013

Starting next year, supplemental and private health insurance companies in Brazil will be required to cover the costs of oral administered medicines for the treatment of cancer patients at home, reports Juliane Carvalho, writing for Brazil Pharma News.

The measure already foreseen in the National Health Agency (ANS) regulation is now a new Law 12.880/13, published in the Federal Gazette on November 14. President Dilma Rousseff signed the Proposal (PL 3998/12) which originated the final law passed in the House of Representatives in August, and in the Senate last October 22.

Congressman Ricardo Berzoini (PT- SP) was the rapporteur for the proposal in the Committee for the Constitution, Justice and Citizenship of the House (CCJ), which highlights the expansion of coverage agreements will improve the quality of life of cancer patients treated at home. "The patient takes the medicine without the need to go to a hospital or a health clinic. Therefore, under strict medical prescription rules, the patient may soon take his/her own medicine at the comfort of their home with no need to travel and undergo the hospitalization," he says.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight